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Abstract
Objective—Shared decision making is inadequate in intensive care units (ICUs). Decision aids
can improve decision making quality, though their role in an ICU setting is unclear. We aimed to
develop and pilot test a decision aid for shared decision makers of patients undergoing prolonged
mechanical ventilation.
Setting—ICUs at three medical centers.
Subjects—53 surrogate decision makers and 58 physicians.
Design and interventions—We developed the decision aid using defined methodological
guidelines. After an iterative revision process, formative cognitive testing was performed among
surrogate-physician dyads. Next, we compared the decision aid to usual care control in a
prospective, before/after design study.
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Measurements and main results—Primary outcomes were physician-surrogate discordance
for expected patient survival, comprehension of relevant medical information, and the quality of
communication. Compared to control, the intervention group had lower surrogate-physician
discordance (7 [10] vs 43 [21]), greater comprehension (11.4 [0.7] vs 6.1 [3.7]), and improved
quality of communication (8.7 [1.3] vs 8.4 [1.3]) (all p<0.05) post-intervention. Hospital costs
were lower in the intervention group ($110,609 vs $178,618; p=0.044); mortality did not differ by
group (38% vs 50%, p=0.95). 94% of surrogates and 100% of physicians reported that the
decision aid was useful in decision making.
Conclusion—We developed a prolonged mechanical ventilation decision aid that is feasible,
acceptable, and associated with both improved decision making quality and less resource
utilization. Further evaluation using a randomized controlled trial design is needed to evaluate the
decision aid's effect on long-term patient and surrogate outcomes.
Keywords
decision aid; decision making; respiration; artificial; critical illness; prolonged mechanical
ventilation
Introduction
Patients with prolonged mechanical ventilation experience high mortality and morbidity,
poor quality of life, and require extended caregiving assistance from families and friends.1, 2
Because the care of these patients is expensive and their number increasing annually,3
prolonged mechanical ventilation is also an extraordinary financial burden for the health
system.1
The decision about whether or not to continue life sustaining therapy in prolonged
mechanical ventilation ideally would be guided by shared decision making—a collaborative
communication process that aims to reach consensus about the treatment that is most
consistent with patient values.4 Although the use of shared decision making is endorsed by
many major critical care professional societies, its implementation in the intensive care unit
(ICU) is incomplete and infrequent.5, 6 Deficiencies in shared decision making include
inadequate provision of medical information such as treatment choices and prognosis,
failure to elicit either understanding of patients' preferences or surrogates preferred
decisional role, and generally poor communication quality.7-12 Together, these deficiencies
can reduce the quality, timeliness, and patient-centeredness of decision making.13, 14
Decision aids could be an effective way to address the problems surrounding decision
making regarding patients undergoing prolonged mechanical ventilation. In general,
decision aids improve the quality of decision making, increase comprehension and
decisional participation, lead to more realistic expectations, improve the likelihood of
solidifying a decision that aligns preferences and choice, and reduce the use of high cost
procedures of unclear benefit.15, 16 Their importance is underscored by their explicit
promotion in the 2010 Affordable Care Act.17 However, decision aids have not been tested
extensively in an ICU setting. The objective of this study was to develop a decision aid for
surrogate decision makers of patients with prolonged mechanical ventilation, and to pilot
test its feasibility, acceptability, and effect on decision making quality and resource
utilization.
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Study design and participants
In this study, we sequentially developed a decision aid, performed formative cognitive
testing among decision aid recipients, and compared the decision aid to usual care control
using a prospective before (control)/after (decision aid) design (Figure 1).
Study staff screened general surgical and trauma, neurological, cardiac, and medical ICUs
daily. Consecutive subjects were eligible if they were the person ≥18 years of age self-
identified as being most involved in medical decision making for each patient mechanically
ventilated for ≥10 days, a common definition for prolonged mechanical ventilation.1 We
excluded surrogates of patients with a tracheotomy placed for either emergency indications
or for an ear, nose, or throat-related diagnosis; pre-admission tracheotomy; admission for
severe burns; expected survival <72 hours, or age <18. We also excluded surrogates who
were not conversational in English. Surrogates received $25 for participation in this study.
We enrolled the primary ICU attending physician at the time of patient eligibility. All study
procedures took place at Duke University, Durham Regional Hospital, and the University of
North Carolina between April 2009 - July 2010 (Figure 1).
Development of the decision aid
Decision aid content derivation—We aimed to develop a decision aid that promoted
the process of individualized shared decision making about whether to provide prolonged
life support to a critically ill loved one.4 Domain and quality criteria specified by
International Patient Decision Aids Standards Collaboration guidelines guided decision aid
development.18 We defined the main decision about prolonged mechanical ventilation
provision as a goal-based prioritization of patient-centered appropriate levels of treatment.
The decision was presented as a continuum of options ranging from maximizing life
prolongation to maximizing comfort; an intermediary area included a choice to aim for
survival but avoid prolonged life support (Figure 2).19 We developed a list of key topics
relevant to decision making from the input of experts in related topic areas(decision making,
communication, geriatrics, palliative care, critical care outcomes, clinical medicine, and
ethics), the medical literature, and informal interviews with physicians and nurses. Decision
aid content was designed to address four main domains of shared decision making:
providing medical information relevant to critical illness, eliciting surrogates' understanding
of patient values and surrogates' role preferences, and guiding deliberation (Figure 3). It
included information on treatments and procedures, as well as individualized probabilistic
information on likely mortality, functional independence, and ultimate disposition derived
from validated models of one-year survival and population-based prospective prolonged
mechanical ventilation studies.1, 2 The decision aid was designed to elicit both the
surrogate's understanding of the patient's life support preferences and their preferred
decision making role trough questions embedded within it.20 The decision aid also aimed to
guide deliberative decision making by prompting the surrogate to consider likely patient
outcomes, the pros and cons of each option, what direction they are leaning in the decision,
and what additional questions remained. Short explanatory stories were included to improve
clarity. One investigator (CEC) compiled this information into an initial self-administered,
printed version that was 10 pages in length, written at a 6th grade reading level, and made
generous use of simple diagrams to illustrate key points as recommended by experts in
decision making.21 The decision was revised slightly after incorporating the feedback on
clarity and completeness from fifteen physicians and ten surrogates as well as from the
group of experts.
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Cognitive testing—Trained research staff used a validated, semi-structured, theory-based
cognitive testing methodology to determine if the decision aid was clear and understandable,
contained acceptable information, and was useful in prolonged mechanical ventilation
decision making.22 A study staff member reviewed each page of the decision aid with
surrogates, asking them with open-ended questions about their general interpretation of the
page's meaning as well as its importance and value to them. Physicians were interviewed in
person on the day of the surrogate interview to obtain their estimate of one-year patient
survival and to rate their acceptability of the decision aid.
Evaluation of the decision aid versus usual care control
Overview—Surrogates and physicians completed identical study questionnaires in person
on the day of enrollment but before the intervention, as well as within two days after a
family-physician meeting. Intervention surrogates reviewed the decision aid after enrollment
and were briefly instructed in its use by study staff; surrogates kept the decision aid
throughout the study period. Control surrogates received no additional information.
Participants in both groups were scheduled to attend an ICU physician-family meeting
within two days of enrollment, generally coinciding with two weeks post-intubation. The
study protocol did not specify the content of this unstructured meeting, requesting only that
physicians ask intervention surrogates if they had any questions about the decision aid
content.
Data collection and outcomes measures—We collected data from in-person
interviews as well as from patients' medical charts including admitting diagnoses,
sociodemographics, Charlson comorbidity scores,23 limitations in activities of daily
living,24, 25 acute physiology scores (APACHE II),26 quality of life (EuroQOL 5-Dimension
Scale),27 symptoms of anxiety and depression (Hospital Anxiety and Depression Scale),28
mechanical ventilation duration and outcome, and hospital and ICU lengths of stay.
The primary outcomes were physician-surrogate discordance for expected one year patient
survival, quality of communication with physicians, and medical comprehension. The
validated physician-surrogate discordance score was calculated as the absolute difference
between physicians' and surrogates' prognostic estimates for one year patient survival on a
0-100% scale.8, 29 Discordance scores can range from 0 (maximal concordance) to 100
(maximal discordance). Physician-surrogate communication was characterized using the
Quality of Communication (QOC) scale, a validated 17-item (mean score range 0 [worst] -
10 [best]) instrument.30 Surrogates' understanding of diagnosis, prognosis, and treatments
was assessed using a 12-item (score range 0 [poor comprehension] to 12 [excellent
comprehension]) adapted version of the medical comprehension scale (MCS).7 Satisfactory
comprehension for each item was defined as either correct identification of each relevant
factor or prognostic estimate within +/-25% of physicians' estimates. The decisional conflict
scale (DCS), a 16-item instrument (lower scores reflecting more uncertainty) was used to
evaluate decisional uncertainty.31 We assessed the feasibility of adoption of the decision aid
using enrollment rates and measured acceptability by query of subjects about whether the
decision aid was an acceptable way to approach the prolonged mechanical ventilation
decision (agree/disagree). Secondary outcomes were measured using single-item, Likert
scale (strongly agree, agree, uncertain, disagree, strongly disagree)measures of surrogates'
trust of ICU physicians, conflict with physicians, and whether physicians discussed patients'
expected one-year survival and functional status. Total hospital costs were gathered from
administrative databases.
Statistical analyses—The sample size was chosen to represent what we felt to be a
reasonable sample (roughly 15%) of ICU patients at our institutions who receive prolonged
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mechanical ventilation, with group division chosen to achieve a 1:1.5 control to intervention
ratio. Categorical data are presented using number (percentage) and continuous data as
means (standard deviations) or medians (interquartile ranges [IQR]). For the prospective
evaluation of the decision aid to control, we used analysis of covariance tests to compare
post-intervention differences in the primary outcomes within subjects between control and
decision aid groups after verifying normality assumptions with Shapiro-Wilk tests,
incorporating baseline questionnaire scores in regression equations.32 For secondary
outcomes, we compared study groups using Fisher's exact tests for categorical variables and
either Kruskal-Wallis tests or t-tests for continuous variables. Because cost data were
skewed, we used generalized linear models with a gamma distribution and a logarithmic link
function to compare total hospital costs by study group.33, 34 We used Stata, version 11
(College Station, TX) for all analyses and considered a p <0.05 to be significant.
Institutional Review Boards at all study sites approved the study procedures. Portions of
these data have been presented previously in abstract form.35
Results
Cognitive testing
16 surrogate decision makers and corresponding patients' 16 primary ICU attending
physicians participated in formative cognitive testing of the decision aid. Surrogates were
diverse in age (range 44-70), gender (55% female), and ethnicity (27% non-white). All
reported that the decision aid was useful in understanding prognosis and treatment options,
as well as motivating them to engage in discussions with the medical team about treatment
options including palliative care; none reported associated psychological distress. All
physicians reported that the decision aid was acceptable and complementary to family
meetings. Prior to viewing the decision aid, only 2 (12%) surrogates could correctly estimate
patients' one year survival within 25% of the physician's estimate, whereas afterward, all 16
(100%) could do so correctly. Further, before viewing the decision aid no surrogates could
articulate any specific goals of treatment other than “survival,” yet afterward all 16 (100%)
accurately described the 3 goals of treatment presented. Minor revisions based on participant
critiques were subsequently incorporated in the final decision aid (Online Supplement).
Evaluation of the decision aid versus usual care control
Baseline characteristics and hospital course—In the prospective evaluation, a total
of 10 surrogate decision makers received usual care and 17 received the decision aid; three
surrogates refused participation. Surrogates were younger and mostly female. Most
surrogates reported symptoms of either depression (85%) or anxiety (70%) on the day of
enrollment. There were no statistically significant between-group differences in
sociodemographic characteristics or psychological distress (Table 1). Patients were
generally elderly, male, and possessed a number of chronic medical comorbidities; few,
however had baseline dependencies in activities of daily living. There were no clinically
important between-group differences in pre-enrollment length of stay. Attending physicians
were from both medical (74%) and surgical (26%) services; no physicians refused
participation.
Outcomes—Compared to control, decision aid recipients had lower post-intervention
physician-surrogate discordance scores for expected one year patient survival (7 [10] vs 43
[21], p=0.001), improved quality of communication scores (8.7 [1.3] vs 8.4 [1.3]; p=0.03),
higher medical comprehension scores (11.4 [0.7] vs 6.1 [3.7], p=0.001), and lower
decisional conflict scale scores (0.2 [0.4] vs 0.9 [0.9], p=0.004) (Figure 3). Decision aid
recipients also had lower physician-surrogate discordance for one-year functional
independence (7 [6] vs 38 [32], p=0.011).
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Secondary outcomes are shown in Table 2. Compared to control, decision aid surrogates
reported more frequent discussions with physicians about expected long-term patient
survival and functional status (both p=0.013). A trend toward improved physician trust and
physician conflict was observed in the intervention group, though this was not statistically
significant. Three (30%) control patients and 10 (59%) intervention patients had a change in
advance directive status during the study (p=0.15). Total hospital costs were lower in the
decision aid group ($110,609 vs $178,618; p=0.044), a finding possibly explained by lower
costs for ICU room (p=0.098), respiratory therapy (p=0.086), and pharmacy (0.002).
Decision aid group patients had numerically fewer ventilator days, ICU days, and hospital
days, though these differences were not statistically significant. There were no clinically
important group differences in discharge disposition or hospital mortality.
Intervention feasibility was demonstrated by the high enrollment rate of eligible subjects
(90%), the fact that all family meetings were held within 2 days of enrollment (70% within
24 hours), and our observation that all subjects were able to review the decision aid within
an hour with no more than fifteen minutes of staff support. Support for the acceptability of
the intervention was demonstrated by the report of 16 (94%) surrogates that the decision aid
was useful in the decision making process; one surrogate felt unprepared to receive the
information contained in the decision aid. All physicians reported that the decision aid was
useful and that its discussion in a family meeting setting was acceptable.
Discussion
In this pilot study among surrogate decision makers of patients with prolonged mechanical
ventilation, we developed a decision aid that was feasibly administered, well accepted by
surrogates and physicians, and associated with improved decision making quality.
Compared to usual care control, the decision aid was associated with improved physician-
surrogate concordance for long-term survival, quality of communication, and medical
comprehension, as well as reduced decisional conflict. Given the trend toward lower length
of stay in the intervention group, there is a suggestion that the decision aid may expedite the
decision making process, thereby reducing resource utilization.
Problems with ICU decision making have been reported for decades. Medical information
including prognosis is often not shared by physicians, is inaccurate, and is poorly understood
by surrogates.7-9, 12, 36-38 This is particularly true in prolonged mechanical ventilation, in
which unrealistically optimistic prognostication among physicians and surrogates is
common.8 These communication deficiencies can impair comprehension, increase
discordance and conflict, and can threaten the patient-centeredness of the decision itself.8, 39
This decision aid is one of the first ICU-based interventions to address specific deficiencies
in informed decision making. It also has potential to improve the process of shared decision
making, a model widely endorsed by consensus groups but uncommonly implemented in
clinical practice.5, 40 The decision aid explicitly promotes shared decision making by
providing medical information, eliciting surrogate decision makers' understanding of patient
preferences and their preferred decision role, and guiding deliberation.6 In so doing, the
decision aid aims to stimulate collaborative communication between physicians and
surrogates, therefore addressing sources of potential conflict and distrust. The decision aid
also represents a pragmatic approach that could be easily disseminated and inexpensively
implemented in clinical practice. Additionally, it targets risk factors for greater length of
stay by encouraging more timely “in the moment” decision making, improving physician
time efficiency, and focusing on causes of surrogate-physician discordance and
conflict.2, 39, 41 By acting as an adjunct to the decision making process, the decision aid also
addresses the time constraints of an ICU workforce gap that will continue to widen in the
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future.42 Further, the decision aid has the potential to improve long-term surrogate decision
maker outcomes because it addresses risk factors for psychological distress including
physician-surrogate discordance, poor communication and comprehension, multiprovider
contradictions, inadequate medical information provision, and elicitation of preferred
decisional roles.7, 13, 43
Our study has several limitations. First, the complexity and individuality of ICU decision
making cannot be distilled completely into a decision aid that at best represents an
adjunctive tool in the surrogate-physician dynamic. The decision aid is not a replacement for
good quality communication and does not address all important end of life issues
confronting providers such as communication skills training, fundamental values conflicts,
prognostic uncertainty, and patients who lack surrogate decision makers. Second, it may be
challenging to implement the decision aid in different populations and care locations.
Specifically, the intervention does not address many of the diverse range of educational,
linguistic, ethnic, cultural, and religious characteristics that may influence surrogates'
decisions and may not address all outcomes of importance to decision makers.44-46 Future
versions of the decision aid could be written at an even lower reading level, translated into
other languages, and adapted to include local sociocultural factors that weigh heavily in
decision making. Third, because print-based decision aids have limited flexibility in
adapting to different user information needs, we are currently evaluating a web-based format
that could also allow widespread, inexpensive access to decision support.47 Fourth,
generalizations about the intervention's benefit are limited by the modest sample size, quasi-
experimental design, and potential differences in case-mix and temporal trends. Group-
based cost differences appear generally related to length of stay, though the notable signal
associated with pharmacy costs may suggest a more specific focus on post-intervention
simplification of management. More detailed study is required with long-term follow up to
determine the decision aid reduces resource utilization, and if so, through what mechanisms.
Because family meetings were not recorded, we are unable to assess how the decision aid
may have affected the surrogate-physician interaction itself. A randomized controlled trial is
needed to determine its efficacy.
Conclusion
We found that a novel decision aid for surrogate decision makers of patients with prolonged
mechanical ventilation was feasible and acceptable, and may improve the quality of ICU
decision making and reduce resource utilization. Additional research is needed to determine
the decision aid's true effectiveness and its impact on long-term outcomes.
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Figure 1. Study overview
This study consisted of the development and evaluation of the decision aid. The
development stage consisted of the creation and the cognitive testing of the decision aid. The
prospective evaluation compared usual care control (“before”) to the decision aid (“after”) in
a pre-post intervention design. The duration of each study component is shown on the right
side of the figure.
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Decision aid display of the clinical choice: goals of treatment.
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Summary of decision aid content.
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Figure 4. Primary outcomes of the prospective evaluation study
Primary study outcomes are compared between decision aid and usual care control groups.
The dark and light bars represent pre- and post-intervention scores, with the corresponding
mean values shown above each. P values are derived from analysis of covariance tests.
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Table 1
Patient and surrogate characteristics in evaluation stage
Characteristic Patients (n=27) Surrogates (n=27)
Age 68 (55, 73) 55 (44, 70)
Female 11 (41%) 17 (63%)
Race & ethnicity*
White 17 (63%) 16 (63%)
African-American 10 (37%) 10 (37%)
Place of residency before admission
Home 24 (89%) 27 (100%)
Nursing facility 1 (4%)
Rehabilitation facility 2 (7%)
Employed, full- or part-time 9 (33%) 11 (40%)
Insurance status
Private 8 (30%)
Government (Medicare or Medicaid) 17 (63%)
Self-pay 2 (7%)
Chronic comorbidities† 4 (3, 5)
Dependencies in activities of daily living‡ 1 (0, 11)
Primary ICU admission diagnosis§
Acute lung injury 9 (33%)
Other respiratory failure 6 (22%)




APACHE II score, ICU day 1 29 (23, 35)
Do not attempt resuscitation order, day of enrollment 0
EuroQOL 5 Dimension index score, day of enrollment 0.84 (0.77, 0.84)
Hospital Anxiety and Depression Scale, day of enrollment
Total score 22 (17, 29)
Depression subscale score >7 23 (85%)
Anxiety subscale score >7 16 (70%)
Results as number (%) or median (interquartile range).
*




ADL and IADL score.
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§
Other respiratory includes pneumonia and chronic obstructive pulmonary disease exacerbations; neurological includes ischemic stroke and
subarachnoid hemorrhage; cardiac includes myocardial infarction and out of hospital cardiac arrest. There were no statistically significant
differences in characteristics listed in the table between patients and surrogates by study group.
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Table 2
Secondary outcomes of prospective evaluation by study group
Characteristic
Study Group
pControl n=10 Decision Aid n=17
Physician discussed long-term survival 3 (30%) 14 (88%) 0.013*
Physician discussed long-term functional status 3 (30%) 14 (88%) 0.013*
Increased trust in physicians 1 (10%) 7 (41%) 0.19*
Surrogate-physician conflict 3 (30%) 2 (12%) 0.33*
Surrogate change in preferences for goals of treatment 3 (30%) 10 (59%) 0.15*
Less aggressive 2 6
More aggressive 1 4
Mechanical ventilator days 34 (18, 49) 22 (14, 46) 0.25†
Mechanical ventilator outcome§ 0.57*
Liberation 3 (30%) 3 (15%)
Tracheotomy 5 (50%) 11 (50%)
Withdrawal from ventilator 2 (20%) 6 (30%)
ICU length of stay 48 (30) 28 (25) 0.08†
Hospital length of stay 57 (33) 37 (32) 0.14†
Hospital mortality 4 (50%) 7 (38%) 0.95*
Hospital costs $178,618 ($115,154) $110,609 ($89,356) 0.044‡
Disposition 0.29*
Home independent 0 0
Home with paid care 1 (13%) 1 (6%)
Long-term acute care facility 1 (13%) 7 (39%)
Skilled nursing facility 1 (13%) 1 (6%)
Rehabilitation facility 3 (38%) 1 (6%)
Other hospital 0 1 (6%)
Dead 4 (50%) 7 (39%)






generalized linear model with gamma distribution and logarithmic linkage.
§
Sum is >100% because of multiple outcomes observed.
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